24 hours
7 days a week
  • 888-584-0411
  • http://seegerweiss.wpengine.com/wp-content/uploads/2007/09/Seeger-Weiss.jpg

    Drug Injury Claims Cause Actos Sales to Plunge

    By: Seeger Weiss LLP on November 4, 2011

    Reports surfaced early today that profits for Japan-based Takeda Pharmaceutical Co. have substantially declined.

    Reports surfaced early today that profits for Japan-based Takeda Pharmaceutical Co. have substantially declined. One factor that several news sources, including Bloomberg Businessweek, have attributed to the company’s losses is the controversy surrounding its top-selling drug, Actos. Calls for the FDA to release cautionary warnings for the diabetes medication began to emerge after it was linked to an increased risk of bladder cancer. Takeda projects that its net income will plunge by over 30 percent over the course of the next four months.

    Seeger Weiss’ highly experienced drug injury practice is closely monitoring reports of bladder cancer associated with Actos. To learn more, visit our Actos investigation page.

    Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

    By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

    Handling Cases Nationwide

    we support

    Sign Up to our Consumer Alerts Newletter
    Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

    By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

    ×